Literature DB >> 181056

Neutral glycosphingolipids of serum lipoproteins in Fabry's disease.

J T Clarke, J M Stoltz, M R Mulcahey.   

Abstract

The neutral glycosphingolipid compositions of lipoprotein fractions of serum from eight healthy male volunteers and three patients with Fabry's disease were determined. Four fractions were studied: very low density lipoprotein (VLDL, d less than 1.006); low density lipoprotein (LDL, d 1.006-1.063); high density lipoprotein (HDL, d 1.063-1.21); and ultracentrifugal residue (Residue, d less than 1.21). All lipoprotein fractions contained the four major neutral glycosphingolipids (glucosylceramide, lactosylceramide, galactosylgalactosylglucosylceramide and N-acetylgalactosaminylgalactosylgalactosylglucosylceramide). The LDL and HDL, however, accounted for most of the total glycosphingolipid (69 and 20%, respectively); only small amounts were demonstrated in the VLDL and Residue. The relative distributions of the glycosphingolipids within the LDL and HDL fractions were similar to the distribution in unfractionated serum. Galactosylgalactosylglucosylceramide levels were 3-5 times normal in all three patients with Fabry's disease, and in two the distribution of the excess lipid among the major lipoprotein fractions was similar to that in the control group. In the third patient, who exhibited the presence of "sinking pre-beta lipoprotein", the amount of glycosphingolipid isolated with the HDL was greater than that in the LDL.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181056     DOI: 10.1016/0005-2760(76)90152-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  A Short Synthetic Peptide Mimetic of Apolipoprotein A1 Mediates Cholesterol and Globotriaosylceramide Efflux from Fabry Fibroblasts.

Authors:  Ulrike Schueler; Christine Kaneski; Alan Remaley; Stephen Demosky; Nancy Dwyer; Joan Blanchette-Mackie; John Hanover; Roscoe Brady
Journal:  JIMD Rep       Date:  2015-12-19

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

3.  Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

Authors:  M W Spence; J T Clarke; D M D'Entremont; G A Sapp; E R Smith; A L Goldbloom; G Davar
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

4.  Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.

Authors:  D Marchesan; T M Cox; P B Deegan
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

5.  Distribution of antithrombin III and glucosylceramide in human plasma lipoproteins and lipoprotein deficient plasma.

Authors:  S Chatterjee; W R Bell; P O Kwiterovich
Journal:  Lipids       Date:  1984-05       Impact factor: 1.880

6.  Lipid profile in adult patients with Fabry disease - Ten-year follow up.

Authors:  Karolina M Stepien; Chris J Hendriksz
Journal:  Mol Genet Metab Rep       Date:  2017-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.